![](/img/cover-not-exists.png)
141 ACTB-1003 - a unique oral pan FGFR and PI3K pathway inhibitor with divergent modes of activity
A. Burd, M. Whiteside, J. Castillo, L. Kunkel, A. FattaeyVolume:
8
Year:
2010
Language:
english
DOI:
10.1016/s1359-6349(10)71846-2
File:
PDF, 43 KB
english, 2010